Skip to main content
BLTE logo
BLTE
(NASDAQ)
Belite Bio, Inc
$169.85-- (--)
Loading... - Market loading

Belite Bio (BLTE) Stock Price & Financial Analysis

Belite Bio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$162.00 - $176.18
52-Week High$200.00
52-Week Low$49.00
Open$162.13
Volume213.95K
Average Volume (3M)213.95K
Market Cap5.64B
Shares Outstanding33.22M
Price to Book (P/B)20.27
EV/EBITDA-84.91
50-Day MA$170.60
200-Day MA$114.03
52-Week Change157.31%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Belite Bio

What is the current stock price for BLTE?

As of the latest trading session, BLTE stock trades at $169.85. The 52-week range is $49.00–$200.00, with a day range of $162.00–$176.18.

What is the P/E ratio for BLTE?

The P/E ratio (Price-to-Earnings) for BLTE is shown in the Key Statistics section. This valuation metric helps compare Belite Bio, Inc to industry peers.

Does BLTE pay dividends?

Belite Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLTE?

Based on 7 analysts, the consensus for BLTE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BLTE?

Belite Bio's market capitalization is $5.64B, classifying it as a mid-cap company. Belite Bio operates in the Healthcare sector within the Biotechnology industry.